Home Featured

Featured

Movers and Shakers: Beigene Ltd (ADR) (NASDAQ:BGNE) and Proteostasis Therapeutics Inc (NASDAQ:PTI)

Jennifer Aldershot - March 8, 2016

Trevena Inc (NASDAQ:TRVN) Just Got Its Billion Dollar Pain Management Bid Underway

Neuralstem, Inc. (NASDAQ:CUR) Is Up. Here’s Why And What It Means

Cynapsus Therapeutics Inc (NASDAQ:CYNA) set for a Game Changing Topline Release

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Is An Attractive Contrarian Entry

Here’s Our Take On The Global Blood Therapeutics Inc (NASDAQ:GBT) Rumors

Mark Collins - March 9, 2017

Here’s What The Latest Nymox Pharmaceutical Corporation (NASDAQ:NYMX) Announcement Means

Mark Collins - March 30, 2017

Here’s Why Axovant Sciences (NASDAQ:AXON) And PTC Therapeutics, Inc. (NASDAQ:PTCT) Are...

Mark Collins - September 27, 2017

Open Label Extension Implies a Favorable Phase II for Corbus Pharmaceuticals...

David Rich - April 12, 2016

Roche Just Picked Up A Range Of Potential Billion Dollar Indications

Mark Collins - December 1, 2015

Sticky Price Inflation Is Already Here, What This Means For Gold

Rafi Farber - September 7, 2016

Why Oil Production Cut Talks Between Iran, OPEC Are Just Noise

Rafi Farber - September 23, 2016

Our Take On Kamada Ltd (NASDAQ:KMDA)’s Upcoming Catalysts

Mark Collins - August 9, 2016

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Scores Big, But Have The Children?

Mark Collins - April 28, 2017

Here’s What You Need to Know About IntelliPharmaCeutics Intl Inc (USA)...

Jennifer Aldershot - July 7, 2016

12 3...69 Page 1 of 69

EDITOR PICKS

Biotech Mergers: Impax Laboratories, Inc. (NASDAQ:IPXL) and Neothetics, Inc. (NASDAQ:NEOT)

October 18, 2017

Here’s What’s Moving Exelixis, Inc. (NASDAQ:EXEL) Right Now

October 17, 2017

Here’s What’s Moving Antares Pharma, Inc. (NASDAQ:ATRS) And Infinity Pharmaceuticals, Inc....

October 16, 2017

This Small Nasdaq Hidden Gem May Have a $2.8B Drug

July 16, 2017

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.